Position in JNJ
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$3,513,420
-$30,471 QoQ
Shares Held
13,834
-4.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#729
of 2,126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $22,172,877 across 17 Drug Manufacturers - General names. JNJ ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,562 | $4,272,370 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
73,361 | $4,227,060 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
13,834 | $3,513,420 | |
| 4 | ABBV |
AbbVie Inc.
|
6,899 | $1,736,064 | |
| 5 | NVS |
Novartis AG
|
10,771 | $1,688,031 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,085 | $1,552,922 | |
| 7 | AZN |
Astrazeneca PLC
|
7,263 | $1,377,210 | |
| 8 | AMGN |
Amgen Inc
|
1,980 | $716,997 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,513,420 | 13,834 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $3,543,891 | 14,498 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,395,860 | 11,577 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $2,201,862 | 11,875 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $1,619,608 | 10,603 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $1,397,202 | 8,425 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $676,532 | 4,678 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $592,977 | 3,659 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $486,274 | 3,327 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $347,227 | 2,195 | Shares | Sole | 2024-04-03 | |
| 2023-12-31 | $384,953 | 2,456 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $387,350 | 2,487 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $427,703 | 2,584 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $396,490 | 2,558 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $416,717 | 2,359 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $417,384 | 2,555 | Shares | Sole | 2022-12-30 | |
| 2022-06-30 | $454,070 | 2,558 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $439,353 | 2,479 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $476,258 | 2,784 | Shares | Sole | 2022-01-06 | |
| 2021-09-30 | $451,877 | 2,798 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $464,237 | 2,818 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $543,669 | 3,308 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $519,983 | 3,304 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $634,079 | 4,259 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $603,021 | 4,288 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $564,252 | 4,303 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||